Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409523 · ClinicalTrials.gov registry record
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes
A clinical trial of Diabete Mellitus, sponsored by NYU Langone Health.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT03409523: Completed study of Diabete Mellitus, sponsored by NYU Langone Health.
NCT03409523 is a study of Diabete Mellitus that has completed, run by NYU Langone Health. The registered enrollment target is 30 participants, below the 203-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03409523, a study of Diabete Mellitus, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will develop a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module will incorporate effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely guidelines; this generally involves less aggressive targets for HbA1c, and reductions of medications other than metformin. The implementation of the module will ultimately be triggered by medication prescribing in EPIC. The BE principles include suggesting alternatives to medications, requiring justification, setting of appropriate default order sets, and incorporation of anchoring and checklists to guide behavior. The study will involve provider workflow analysis based on observation, module user testing, and live usability testing with direct observation and semi-structure interviews.
Primary Outcome
The implementation of the module will ultimately be triggered by medication prescribing in EPIC.
Conditions Studied
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2019-07-03 |
What the finished NCT03409523 record still lists
NCT03409523 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 203-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Diabete Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT03409523 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03409523 about?
NCT03409523 is a clinical study titled "An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes". This study will develop a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module will incorporate effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely guidelines...
What is the current status of trial NCT03409523?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-01-08. Estimated completion is 2019-07-03.
What conditions does trial NCT03409523 study?
This clinical trial studies the following conditions: Diabete Mellitus.
Who is sponsoring clinical trial NCT03409523?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03409523 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabete Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
RECRUITING · NA
-
FSL2 Post Approval Study for Pediatric and Young Adults Patients
RECRUITING
-
Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing
RECRUITING · Phase 4
-
StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
COMPLETED
-
Study of an Interstitial Fluid Glucose Sensor
COMPLETED · NA
-
FreeStyle Libre Flash Glucose Monitoring System Accuracy
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI